RELEReleases

Pulsenmore Secures $7.5 Million in Private Placement

Ramat Gan-based Pulsenmore Ltd. has finalized a $7.5 million private placement with a healthcare-focused institutional investor. The deal involves the sale of over 1.5 million ordinary shares and accompanying warrants, providing the ultrasound technology firm with fresh capital to accelerate its U.S. commercial expansion and strategic initiatives.

Bio & NewsJune 25, 2026986 reads0

The offering is priced at $4.80 per unit, a premium over the Nasdaq minimum price requirement. Under the terms of the agreement, investors receive ordinary shares—or pre-funded warrants—alongside warrants exercisable at $4.80 over a five-year period. A.G.P./Alliance Global Partners served as the sole placement agent for the transaction.

CEO Elazar Sonnenschein stated that the capital injection is intended to broaden the company’s commercial footprint and drive long-term growth. Pulsenmore plans to allocate the net proceeds toward marketing, commercialization, and general working capital. The closing is expected around June 26, 2026, pending standard conditions. While the securities are currently exempt from registration, Pulsenmore has committed to filing a registration statement with the SEC to cover the future resale of the shares and those underlying the warrants.

Comments (0)

Leave a comment

No comments yet. Be the first!